{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-020408","form_type":"8-K","ticker":"LIXT","cik":"0001335105","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","filed_at":"2025-07-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.766866+00:00","generated_at":"2026-05-18T04:58:36.347738+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lixte appoints two new independent directors; CMO resigns effective July 31","bullets":["Board adds Jason Sawyer and Dr. Michael Holloway as independent directors, designated by Series B Preferred Stock holders.","Dr. Stephen Forman and Dr. Yun Yen resign from Board, will serve on Scientific Advisory Committee.","Mr. Sawyer named Chairman of Compensation Committee and member of Audit Committee.","Chief Medical Officer Dr. Jan Schellens resigns effective July 31, 2025; consulting agreement terminated.","Resignations not due to any disagreement with company operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-020408","json":"https://secwatch.observer/filing/0001641172-25-020408.json","markdown":"https://secwatch.observer/filing/0001641172-25-020408.md","text":"https://secwatch.observer/filing/0001641172-25-020408.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1335105/000164117225020408/0001641172-25-020408-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1335105/000164117225020408/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T04:58:36.347738+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}